Clinical Trials Directory

Trials / Sponsors / Entasis Therapeutics

Entasis Therapeutics

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With I
Acinetobacter Baumannii-calcoaceticus Complex, Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia
Phase 32019-09-05
CompletedStudy to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subj
Acinetobacter Baumannii-calcoaceticus Complex Infections
Phase 12019-06-21
CompletedStudy Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers
Acinetobacter Baumannii-calcoaceticus Complex Infections
Phase 12019-05-23
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Proc
Healthy Volunteers
Phase 12018-03-16
CompletedEvaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults Wit
Complicated Urinary Tract Infection, Acute Pyelonephritis
Phase 22018-01-17
CompletedEvaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered
Acinetobacter Baumannii Infection
Phase 12017-10-03
CompletedStudy to Determine and Compare Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy Su
Healthy
Phase 12017-08-21
CompletedEvaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Sub
Acinetobacter Baumannii Infection
Phase 12016-10-01
CompletedAZD0914 Phase 1 ADME Study in Healthy Volunteers
Healthy
Phase 12015-01-01